What is Dizal (Jiangsu) Pharmaceutical Co EV-to-Revenue?
EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Dizal (Jiangsu) Pharmaceutical Co's enterprise value is ¥17,381.6 Mil.
Dizal (Jiangsu) Pharmaceutical Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ¥172.6 Mil. Therefore, Dizal (Jiangsu) Pharmaceutical Co's EV-to-Revenue for today is 100.70.
The historical rank and industry rank for Dizal (Jiangsu) Pharmaceutical Co's EV-to-Revenue or its related term are showing as below:
SHSE:688192'
s EV-to-Revenue Range Over the Past 10 Years
Min: 83.81 Med: 1266.13 Max: 5523.59
Current: 100.7
During the past 6 years, the highest EV-to-Revenue of Dizal (Jiangsu) Pharmaceutical Co was 5523.59. The lowest was 83.81. And the median was 1266.13.
SHSE:688192's EV-to-Revenue is ranked worse than 96.68% of 1023
companies
in the Drug Manufacturers industry
Industry Median: 2.26
vs SHSE:688192: 100.70
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Dizal (Jiangsu) Pharmaceutical Co EV-to-Revenue Chart
Competitive Comparison of Dizal (Jiangsu) Pharmaceutical Co's EV-to-Revenue
For the Drug Manufacturers - Specialty & Generic subindustry, Dizal (Jiangsu) Pharmaceutical Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dizal (Jiangsu) Pharmaceutical Co's EV-to-Revenue Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Dizal (Jiangsu) Pharmaceutical Co's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Dizal (Jiangsu) Pharmaceutical Co's EV-to-Revenue falls into.
Dizal (Jiangsu) Pharmaceutical Co EV-to-Revenue Calculation
Dizal (Jiangsu) Pharmaceutical Co's current Enterprise Value is ¥17,381.6 Mil.
Dizal (Jiangsu) Pharmaceutical Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥172.6 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dizal (Jiangsu) Pharmaceutical Co (SHSE:688192) EV-to-Revenue Explanation
Dizal (Jiangsu) Pharmaceutical Co's share price for today is ¥42.08.
Dizal (Jiangsu) Pharmaceutical Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.42.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dizal (Jiangsu) Pharmaceutical Co EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Dizal (Jiangsu) Pharmaceutical Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Dizal (Jiangsu) Pharmaceutical Co (SHSE:688192) Business Description
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SHSE:688192 has been successfully added to your 